The search frequency for Genexine, a company known for specializing in the development of biopharmaceuticals, has recently surged.

As of 9:30 AM on the 15th, Genexine's stock price rose 1.75% from the previous day to 93,000 KRW, with a trading volume of 399,852 shares, which is about 15.3% of the 5-day average trading volume.

On June 12, Genexine became a market topic with the headline "COVID-19 vaccine clinical trials stall... fluctuating around the peak."

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing